• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病患者血清全段甲状旁腺激素水平与血细胞比容的关系

Relation between Serum Intact Parathyroid Hormone Level and Hematocrit in Chronic Kidney Disease Patients.

作者信息

Adhikary L P, Pokhrel A, Yadava S K, Khadka D, Thakur R

机构信息

Division of Nephrology, Department of Internal Medicine, Kathmandu Medical College Teaching Hospital, Sinamangal, Kathmandu, Nepal.

出版信息

Kathmandu Univ Med J (KUMJ). 2015 Jul-Sep;13(51):220-3. doi: 10.3126/kumj.v13i3.16811.

DOI:10.3126/kumj.v13i3.16811
PMID:27180367
Abstract

Background Anemia is a common complication of chronic kidney disease. There are various causes of anemia in chronic kidney disease patients on hemodialysis. Secondary hyperparathyroidism is one of the less recognized causes of anemia in chronic kidney disease patients. Objectives The main objective of the study is to find the correlation between intact parathyroid hormone and hematocrit level in chronic kidney disease (CKD) patients undergoing hemodialysis. Method Verbal consent was taken from all the participants. Eighty participants between the age of 29 and 70 years with chronic kidney disease having indication of hemodialysis were included in this study. Hematocrit was measured by bioelectrical impedance method and serum intact parathyroid hormone was by using Chemi Luminescence Immuno Assay (CLIA) method. Result A weak reverse correlation was found between serum intact parathyroid level and hematocrit (r= -0.33). Conclusion In chronic kidney disease patient, there is reverse correlation between level of serum intact parathyroid and hematocrit level. This association may have clinical relevance in assessing the cause of unexplained low hemoglobin level in CKD patients.

摘要

背景

贫血是慢性肾脏病的常见并发症。血液透析的慢性肾脏病患者贫血的病因多种多样。继发性甲状旁腺功能亢进是慢性肾脏病患者贫血的较少被认识的病因之一。

目的

本研究的主要目的是找出接受血液透析的慢性肾脏病(CKD)患者中完整甲状旁腺激素与血细胞比容水平之间的相关性。

方法

获得了所有参与者的口头同意。本研究纳入了80名年龄在29至70岁之间、患有慢性肾脏病且有血液透析指征的参与者。血细胞比容采用生物电阻抗法测量,血清完整甲状旁腺激素采用化学发光免疫分析(CLIA)法测定。

结果

血清完整甲状旁腺水平与血细胞比容之间存在弱负相关(r = -0.33)。

结论

在慢性肾脏病患者中,血清完整甲状旁腺水平与血细胞比容水平呈负相关。这种关联在评估CKD患者不明原因的低血红蛋白水平的病因方面可能具有临床意义。

相似文献

1
Relation between Serum Intact Parathyroid Hormone Level and Hematocrit in Chronic Kidney Disease Patients.慢性肾脏病患者血清全段甲状旁腺激素水平与血细胞比容的关系
Kathmandu Univ Med J (KUMJ). 2015 Jul-Sep;13(51):220-3. doi: 10.3126/kumj.v13i3.16811.
2
Relation between Calcium, Phosphorus, Calcium-Phosphorus Index and iPTH in Chronic Kidney Disease Patients.慢性肾脏病患者钙、磷、钙磷指数与全段甲状旁腺激素的关系
J Nepal Health Res Counc. 2015 Jan-Apr;13(29):50-3.
3
Emerging Association Between Parathyroid Hormone and Anemia in Hemodialysis Patients.血液透析患者中甲状旁腺激素与贫血之间的新关联。
Ther Apher Dial. 2018 Jun;22(3):242-245. doi: 10.1111/1744-9987.12685. Epub 2018 May 16.
4
Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis.老年慢性肾脏病血液透析患者甲状旁腺功能障碍的危险因素
Adv Clin Exp Med. 2015 Nov-Dec;24(6):1007-12. doi: 10.17219/acem/23439.
5
Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.甲状旁腺激素在肾衰竭贫血中作为红细胞生成抑制剂的潜在作用。
J Lab Clin Med. 1984 Dec;104(6):1016-26.
6
Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.血清甲状旁腺激素和骨髓纤维化对尿毒症患者促红细胞生成素反应的影响。
N Engl J Med. 1993 Jan 21;328(3):171-5. doi: 10.1056/NEJM199301213280304.
7
Is anemia of chronic renal failure related to secondary hyperparathyroidism?
Arch Intern Med. 1981 Mar;141(4):453-5.
8
The relationship between total mass and blood supply of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.继发性甲状旁腺功能亢进血液透析患者甲状旁腺总质量、血供与其甲状旁腺激素分泌之间的关系
Saudi J Kidney Dis Transpl. 2016 Mar;27(2):263-9. doi: 10.4103/1319-2442.178257.
9
Anemia and secondary hyperparathyroidism in chronically hemodialyzed patients.长期血液透析患者的贫血和继发性甲状旁腺功能亢进
Isr J Med Sci. 1979 May;15(5):415-7.
10
Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.慢性血液透析患者继发性甲状旁腺功能亢进治疗方法的近期变化及其与预后的关系:透析预后与实践模式研究(DOPPS)
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):98-109. doi: 10.2215/CJN.12941213. Epub 2014 Dec 16.

引用本文的文献

1
Progress of chronic kidney disease and associated predictors among patients under treatment at Gambi and Felege-Hiwote hospitals.甘比医院和费莱格-希沃特医院接受治疗的患者中慢性肾脏病的进展及相关预测因素
Sci Rep. 2025 Aug 2;15(1):28213. doi: 10.1038/s41598-025-13031-1.
2
Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan.贫血与甲状旁腺激素水平及其他因素在接受血液透析的终末期肾病患者中的相关性:巴基斯坦真实世界横断面数据研究。
Int J Clin Pract. 2023 Feb 13;2023:7418857. doi: 10.1155/2023/7418857. eCollection 2023.
3
Study of Red Cell Fragility in Different Stages of Chronic Kidney Disease in Relation to Parathyroid Hormone.
慢性肾脏病不同阶段红细胞脆性与甲状旁腺激素关系的研究
J Clin Diagn Res. 2017 Aug;11(8):BC29-BC32. doi: 10.7860/JCDR/2017/27344.10514. Epub 2017 Aug 1.